In addition, prostate cancer cell-secreted PTHrP may stimulate the differentiation and maturation of osteoclast cells by altering the homeostasis between the osteoclastogenesis inducer RANKL and its decoy receptor Osteoprotegerin (OPG) in metastatic niches [12–15]. Here, TNFRSF11B is linked to prostate carcinoma.